U.S., April 7 -- ClinicalTrials.gov registry received information related to the study (NCT07511517) titled 'BladMetrix Urine Test for Monitoring Recurrence in Non-Muscle Invasive Bladder Cancer' on March 30.
Brief Summary: This observational study evaluates the urine test BladMetrix for monitoring bladder cancer recurrences in people with non muscle invasive bladder cancer (NMIBC) who are in follow-up after surgery. The main goal is to evaluate the potential clinical utility of the BladMetrix test by comparing its performance with current follow-up methods, cystoscopy (looking into the bladder with a camera) and urine cytology (examining cells in the urine), using confirmed pathological histology as the reference standard for recurrence (...